Articles - Alpharmaxim

Alpharmaxim in the press

With many organisations beginning to invest in behavioural science, we’ve been shouting in the press about the benefits for pharma companies.

Employee engagement, brand alignment, sharing expertise to solve problems: these are all things that internal communications can achieve.

Progress brings new challenges, and help is needed. It might be time for behavioural science to play a bigger part than ever before.

Plain language summaries can translate complex science for different audiences. But what are they, and how do they improve awareness?

We examine what lessons we can take from the COVID-19 vaccine campaigns, and how behavioural science insights may help to drive vaccine uptake.

Over the coming months, we’ll be looking at how new, tailored approaches to communications could help transform the rare disease landscape.

In recognition of World Alzheimer’s Month, we created an animation to explore how Alzheimer’s disease affects patients and their families.

In this latest animation, we explore how a behavioural science-driven approach can help us to better understand the reasons behind vaccine hesitancy.

For World Parkinson’s Day 2023, Alpharmaxim created an animation to highlight some of the Parkinson’s symptoms to look out for.

Join us in our latest #intheframe series as we dive deep into the complex issue of vaccine hesitancy and the barriers preventing its acceptance.